The number of people with susceptibility test result for rifampicin in Austria
Austria: The number of people with susceptibility test result for rifampicin was 165 in 2021. ▼ Falling
Latest (2021)
165
Change on year
down 4.6%
World rank
98th
of 155 countries
All-time high
262
in 2017
All-time low
165
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Austria, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Austria is 165, measured in 2021. That is the lowest value across all 5 years on record.
The figure is down 4.6% on the previous year and down 37.0% over five years.
That places Austria 98th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Austria, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 262 | — |
| 2018 | 208 | -20.6% |
| 2019 | 192 | -7.7% |
| 2020 | 173 | -9.9% |
| 2021 | 165 | -4.6% |
Austria compared with similar countries
- Austria's 165 is above the median for high income countries, which is 142, 1.2× the median. (61 countries reporting)
- Austria's 165 is below the median for Europe & Central Asia, which is 229.5, 72% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 220.67 | 192 | 262 | 3 |
| 2020s | 169 | 165 | 173 | 2 |
Countries ranked near Austria
More health data for Austria
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.05 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,266 deaths per 1,000 people (2090)
- Number of infants who die before age 1 27 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.92 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0217 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.86 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Austria?
- The number of people with susceptibility test result for rifampicin in Austria was 165 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Austria?
- The highest recorded value was 262 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Austria?
- The lowest recorded value was 165 in 2021.
- How does Austria rank for the number of people with susceptibility test result for rifampicin?
- Austria ranks 98th out of 155 countries with data for 2021.
- Where does this Austria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).